DE3786896T2 - Verwendung eines Spermin-Derivats mit anti-neoplastischer Wirkung zur Herstellung pharmazeutischer Zusammensetzungen. - Google Patents

Verwendung eines Spermin-Derivats mit anti-neoplastischer Wirkung zur Herstellung pharmazeutischer Zusammensetzungen.

Info

Publication number
DE3786896T2
DE3786896T2 DE87310591T DE3786896T DE3786896T2 DE 3786896 T2 DE3786896 T2 DE 3786896T2 DE 87310591 T DE87310591 T DE 87310591T DE 3786896 T DE3786896 T DE 3786896T DE 3786896 T2 DE3786896 T2 DE 3786896T2
Authority
DE
Germany
Prior art keywords
general formula
production
pharmaceutical compositions
stands
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE87310591T
Other languages
English (en)
Other versions
DE3786896D1 (de
Inventor
Raymond J Bergeron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
Original Assignee
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida filed Critical University of Florida
Publication of DE3786896D1 publication Critical patent/DE3786896D1/de
Application granted granted Critical
Publication of DE3786896T2 publication Critical patent/DE3786896T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/04—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/06—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms
    • C07C209/08—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/14—Amines containing amino groups bound to at least two aminoalkyl groups, e.g. diethylenetriamines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Hematology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE87310591T 1986-12-02 1987-12-01 Verwendung eines Spermin-Derivats mit anti-neoplastischer Wirkung zur Herstellung pharmazeutischer Zusammensetzungen. Expired - Fee Related DE3786896T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93683586A 1986-12-02 1986-12-02

Publications (2)

Publication Number Publication Date
DE3786896D1 DE3786896D1 (de) 1993-09-09
DE3786896T2 true DE3786896T2 (de) 1993-12-23

Family

ID=25469139

Family Applications (2)

Application Number Title Priority Date Filing Date
DE87310591T Expired - Fee Related DE3786896T2 (de) 1986-12-02 1987-12-01 Verwendung eines Spermin-Derivats mit anti-neoplastischer Wirkung zur Herstellung pharmazeutischer Zusammensetzungen.
DE3751764T Expired - Fee Related DE3751764T2 (de) 1986-12-02 1987-12-01 Verfahren zur Herstellung von N1,N4-Diethylspermin

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3751764T Expired - Fee Related DE3751764T2 (de) 1986-12-02 1987-12-01 Verfahren zur Herstellung von N1,N4-Diethylspermin

Country Status (6)

Country Link
EP (2) EP0270349B1 (de)
JP (1) JPH0653661B2 (de)
AT (1) ATE136021T1 (de)
CA (1) CA1305425C (de)
DE (2) DE3786896T2 (de)
ES (2) ES2059398T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091576A (en) * 1986-12-02 1992-02-25 University Of Florida Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US5753714A (en) * 1987-02-03 1998-05-19 Merrell Pharmaceuticals Inc. Polyamine derivatives
US5654484A (en) * 1987-10-08 1997-08-05 Merrell Pharmaceuticals Inc. Polyamine derivatives as antineoplastic agents
ZA887410B (en) * 1987-10-08 1989-06-28 Merrell Dow Pharma Polyamine derivatives as antineoplastic agents
EP0378146B1 (de) * 1989-01-10 1995-03-29 Merrell Pharmaceuticals Inc. Polyamin-Derivate als antineoplastische Mittel
US5561136A (en) * 1990-12-13 1996-10-01 Merrell Pharmaceuticals Inc. Method of treating cancer by conjunctive therapy with N,N'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent
GB9105489D0 (en) * 1991-03-15 1991-05-01 Johnson Matthey Plc Improvements in chemical compounds
FR2714052B1 (fr) * 1993-12-22 1996-02-02 Synthelabo Préparation de polyamines substituées sur les deux azotes terminaux.
ATE169614T1 (de) * 1993-12-27 1998-08-15 Ciba Geigy Ag Ungesättigte aminoverbindungen zur verwendung als antikrebsmittel und als mittelgegen protozoen
DE69615669T2 (de) * 1995-03-15 2002-07-11 Novartis Ag Piperidenyl-2-alkyl substituierte lineare polyamine zur senkung intrazellulärer, endogener polyaminkonzentrationen wie z.b. putrescin, spermidin und spermin und ihr einfluss auf die zellvermehrung
ES2171911T3 (es) * 1996-10-18 2002-09-16 Wisconsin Alumni Res Found Poliaminas conformacionalmente restringidas y su uso como agentes antineoplasicos.
US5889061A (en) * 1997-10-15 1999-03-30 Wisconsin Alumni Research Foundation Conformationally restricted polyamines
WO2003013245A1 (en) 2001-08-07 2003-02-20 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
EP3189091A2 (de) * 2014-07-11 2017-07-12 Genzyme Corporation Hauptkettenpolyamine
WO2018059214A1 (zh) * 2016-09-29 2018-04-05 广州君赫生物科技有限公司 影响saicar合成的化合物及应用
EP3613731A4 (de) 2017-04-20 2021-01-13 Geneheal Biotechnology Co., Ltd. Anwendungen von spermidin und dessen derivaten
JP6810814B2 (ja) 2017-04-20 2021-01-06 広州君赫生物科技有限公司 抗腫瘍薬の調製におけるスペルミン及びその誘導体の使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS606348B2 (ja) * 1976-03-31 1985-02-18 三菱化学株式会社 新規ポリアミン類
JPS5998015A (ja) * 1982-11-27 1984-06-06 Microbial Chem Res Found 免疫賦活剤

Also Published As

Publication number Publication date
DE3786896D1 (de) 1993-09-09
EP0536853A3 (en) 1993-05-12
JPS63211225A (ja) 1988-09-02
CA1305425C (en) 1992-07-21
EP0536853B1 (de) 1996-03-27
EP0270349A3 (en) 1990-09-12
ATE136021T1 (de) 1996-04-15
DE3751764D1 (de) 1996-05-02
EP0270349B1 (de) 1993-08-04
DE3751764T2 (de) 1996-10-31
JPH0653661B2 (ja) 1994-07-20
ES2059398T3 (es) 1994-11-16
EP0536853A2 (de) 1993-04-14
EP0270349A2 (de) 1988-06-08
ES2088091T3 (es) 1996-08-01

Similar Documents

Publication Publication Date Title
DE3786896T2 (de) Verwendung eines Spermin-Derivats mit anti-neoplastischer Wirkung zur Herstellung pharmazeutischer Zusammensetzungen.
ATE150462T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
AR240830A2 (es) Procedimiento para preparar derivados de acidos naftiridin quinolin-y benzoxazincarboxilicos.
PT79834B (fr) Procede de preparation de nouveaux derives de la xanthine
KR880012526A (ko) l-페닐-3-나프탈레닐옥시프로판아민
MX9200063A (es) Derivados de acidos tetrahidrofolicos y procedimiento para su preparacion.
DE3777852D1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
ES2051479T3 (es) Uso de imidazoles substituidos en 4 para disminuir la presion intraocular.
ATE141606T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung
ATE108440T1 (de) Arylaralkylether, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
IL83850A (en) N-phenylalkyl-amino-alkyl-tetrahydronaphthalene or indane derivatives,their preparation and pharmaceutical compositions containing them
KR890003775A (ko) 결정성 세파드록실 모노하이드레이트의 제조방법
KR950701907A (ko) 데스페리옥사민-B 염 및 경구투여에 유효한 철 킬레이트화제로서의 이의 용도(Desferrioxamine-B salts and their use as orally effective iron chelators)
ES8205207A1 (es) Un procedimiento para la preparacion de una sal de amina
ES2170758T3 (es) Antibioticos novedosos de cefalosporina y procedimientos para la preparacion de los mismos.
ATE101391T1 (de) Verfahren zur herstellung von in stellung 3 durch eine halogenierte gesaettigte kette substituierten cyclopropancarbonsaeurederivaten.
ATE21387T1 (de) Hydrochinonabkoemmlinge, sowie verfahren zu deren herstellung.
SE8800846L (sv) Optiskt aktiva oxo-isoindolinderivat
KR910004632A (ko) 신규한 1-옥사-2-옥소-8-아자스피로[4,5]데칸 유도체와 그들을 포함하는 약제학적 조성물 및 그 제조방법
ES532662A0 (es) Procedimiento para la preparacion de derivados de benzazepina.
KR910015578A (ko) 락탐 유도체의 제조방법
IL59358A (en) Hydroxytetrahydro(phenoxymethyl)-imidazothiazole and thiazolopyrimidine derivatives,their preparation and pharmaceutical compositions containing them
ES2057282T3 (es) 3-aminosidnoniminas substituidas, procedimiento para su obtencion y su empleo.
KR920016451A (ko) 광학 활성 아미노 케톤 유도체 및 그의 제조방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee